Phase IIICompletedBPC-RS-302BREATHE-12: Respiral 250 mcg vs placebo in moderate asthmaPrimary endpoint: Change in trough FEV1 at week 12Enrolment: 2,380 · Sites: Australia, United Kingdom, Brazil, South Korea
Phase IIActive, not recruitingBPC-RS-205BREATHE-TEEN: Growth velocity in adolescentsPrimary endpoint: Linear growth velocity over 52 weeksEnrolment: 410 · Sites: Australia, New Zealand